Abstract:As potential antitumor agents, new benzimidazole thiourea derivatives were designed and synthesized. Compounds 7i, 7j, and 7l showed substantial activity against leukemia cell lines in the National Cancer Institute five‐dose assay, with GI50 values ranging from 1.26 to 4.01 μM. Compound 7l, the most active member, inhibited vascular ‎endothelial growth factor receptor 2 (VEGFR‐2) with an IC50 of 63 nM, and triggered apoptosis and cycle arrest in the HL‐60(TB) leukemia cell line. Novel benzimidazole thiourea derivatives were designed and synthesized based on sorafenib as a lead compound. The benzimidazole moiety was traded by the pyridine ring to enhance the hydrophobic interaction and retain hydrogen bonding in the hinge region, while lipophilic moieties with different bulkiness were employed in the deep hydrophobic pocket for better hydrophobic interactions. Thiourea as a urea bioisostere was also utilized. Substantial activity was demonstrated against a leukemia subpanel in an in vitro antitumor screening at the NCI. In the single‐dose assay, compounds 7i, 7j, and 7l had a GI%) higher than sorafenib against most leukemia cell lines (GI% = 86.2%–137.1%), while in the five‐dose assay, compound 7l outperformed sorafenib against the HL‐60(TB) and SR leukemia cell lines in terms of GI50, TGI, and LC50. Compound 7l also caused cycle arrest at the G0–G1 and S phases in the HL‐60(TB) leukemia cell line and induced apoptosis via elevating the Bax/Bcl‐2 ratio and increasing caspases 3, 7, and 9 by 5.1‐, 3.2‐, and 5.2‐fold, respectively. Compounds 7i, 7j, and 7l also inhibited the vascular ‎endothelial growth factor receptor‐2 (VEGFR‐2), B‐Raf(V600E), and platelet‐derived growth factor receptor ‎beta (PDGFR‐β) enzymes with an IC50 range of 0.063–0.44 μM. COMPARE analysis and a molecular docking study were also performed to predict the possible mechanism of action and binding mode, respectively.

Design and Synthesis of Thiourea Derivatives Containing a Benzo[5,6]cyclohepta[1,2-B]pyridine Moiety As Potential Antitumor and Anti-Inflammatory Agents.

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis, Structure and Biological Evaluation of Thiourea Derivatives As Antitumor Agents

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.

Design, synthesis, and evaluation of new benzimidazole‏ ‏‎thiourea ‎derivatives as antitumor agents

Design, Synthesis and Evaluation of Benzenesulfonamide-Substituted 1,5-Diarylpyrazoles Containing Phenylacetohydrazide Derivatives As Cox-1/Cox-2 Agents Against Solid Tumors

Design, Synthesis and Antitumor Assessment of Phenylureas Bearing 5-Fluoroindolin-2-one Moiety

Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents

Novel 1,3,4-Oxadiazole Thioether Derivatives Targeting Thymidylate Synthase As Dual Anticancer/antimicrobial Agents.

Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity

Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.

Synthesis, Biological Evaluation and Molecular Modeling of 1,3,4-Thiadiazol-2-amide Derivatives As Novel Antitubulin Agents.

Concise Synthesis and Biological Evaluation of 2-Aroyl-5-amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents

Design, Synthesis and Evaluation of Novel Diaryl Urea Derivatives As Potential Antitumor Agents.

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Design, Synthesis and Biological Evaluation of 3,5-Disubstituted 2-Amino Thiophene Derivatives As a Novel Class of Antitumor Agents

Synthesis and Anti-Tumor Activities of N′-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone Derivatives

ChemInform Abstract: Synthesis, Molecular Modeling and Biological Evaluation of 2‐(benzylthio)‐5‐aryloxadiazole Derivatives As Antitumor Agents.